Repression of miR-17-5p with elevated expression of E2F-1 and c-MYC in non-metastatic hepatocellular carcinoma and enhancement of cell growth upon reversing this expression pattern

Biochemical and Biophysical Research Communications

Volumn 434, Issue 3, 2013, Pages 421-427

  El Tayebi, H M ^a   Omar, K ^a   Hegy, S ^a   El Maghrabi, M ^a   El Brolosy, M ^a   Hosny, K A ^b   Esmat, G ^b   Abdelaziz, A I ^a  

^a German University in Cairo   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

c MYC; E2F 1; miR 17 5p; Non metastatic hepatocellular carcinoma

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 17 5P; MYC PROTEIN; OLIGONUCLEOTIDE; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; E2F1 PROTEIN, HUMAN; MIRN17 MICRORNA, HUMAN;

ADULT; ALGORITHM; ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BIOINFORMATICS; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLONOGENESIS; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION; WOUND HEALING; CASE CONTROL STUDY; CELL DIVISION; CELL LINE; GENETICS; LIVER TUMOR; ONCOGENE MYC; PATHOLOGY;

ADULT; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL DIVISION; CELL LINE; E2F1 TRANSCRIPTION FACTOR; FEMALE; GENES, MYC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED;

MLCS; MLOWN;

EID: 84880465468     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.003     Document Type: Article

References (33)

1. G. Leone, J. DeGregori, R. Sears, L. Jakoi, J.R. Nevins, Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F, Nature 387 (1997) 422-426.
2. I. Matsumura, H. Tanaka, Y. Kanakura, E2F1 and c-Myc in cell growth and death, Cell Cycle 2 (2003) 333-338.
3. F. Oswald, H. Lovec, T. Moroy, M. Lipp, E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions, Oncogene 9 (1994) 2029-2036.
4. H.A. Coller, J.J. Forman, A. Legesse-Miller, Myc'ed messages: myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron, PLoS Genet. 3 (2007) e146.
5. N. Cloonan, M.K. Brown, A.L. Steptoe, S. Wani, W.L. Chan, A.R. Forrest, G. Kolle, B. Gabrielli, S.M. Grimmond, The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition, Genome Biol. 9 (2008) R127.
6. M. Wang, H. Gu, H. Qian, W. Zhu, C. Zhao, X. Zhang, Y. Tao, L. Zhang, W. Xu, miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation, Eur. J. Cancer (2013). http://dx.doi.org/10.1016/j.ejca.2012.12.017. [Epub ahead of print].
7. Y. Hayashita, H. Osada, Y. Tatematsu, H. Yamada, K. Yanagisawa, S. Tomida, Y. Yatabe, K. Kawahara, Y. Sekido, T. Takahashi, A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation, Cancer Res. 65 (2005) 9628-9632.
8. L. Venturini, K. Battmer, M. Castoldi, B. Schultheis, A. Hochhaus, M.U. Muckenthaler, A. Ganser, M. Eder, M. Scherr, Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells, Blood 109 (2007) 4399-4405.
9. A. Rinaldi, G. Poretti, I. Kwee, E. Zucca, C.V. Catapano, M.G. Tibiletti, F. Bertoni, Concomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphoma, Leuk. Lymphoma 48 (2007) 410-412.
10. F. Yang, Y. Yin, F. Wang, Y. Wang, L. Zhang, Y. Tang, S. Sun, MiR-17-5p promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway, Hepatology 51 (2010) 1614-1623.
11. H. Kutay, S. Bai, J. Datta, T. Motiwala, I. Pogribny, W. Frankel, S.T. Jacob, K. Ghoshal, Downregulation of miR-122 in the rodent and human hepatocellular carcinomas, J. Cell. Biochem. 99 (2006) 671-678.
12. E. Connolly, M. Melegari, P. Landgraf, T. Tchaikovskaya, B.C. Tennant, B.L. Slagle, L.E. Rogler, M. Zavolan, T. Tuschl, C.E. Rogler, Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype, Am. J. Pathol. 173 (2008) 856-864.
13. C. Schlaeger, T. Longerich, C. Schiller, P. Bewerunge, A. Mehrabi, G. Toedt, J. Kleeff, V. Ehemann, R. Eils, P. Lichter, et al., Etiology-dependent molecular mechanisms in human hepatocarcinogenesis, Hepatology 47 (2008) 511-520.
14. S. Kawate, T. Fukusato, S. Ohwada, A. Watanuki, Y. Morishita, Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression, Oncology 57 (1999) 157-163.
15. S.Y. Peng, P.L. Lai, H.C. Hsu, Amplification of the c-myc gene in human hepatocellular carcinoma: biologic significance, J. Formos. Med. Assoc. 92 (1993) 866-870.
16. L.E. Huang, Carrot and stick: HIF-alpha engages c-Myc in hypoxic adaptation, Cell Death Differ. 15 (2008) 672-677.
17. T. Nakajima, K. Yasui, K. Zen, Y. Inagaki, H. Fujii, M. Minami, S. Tanaka, M. Taniwaki, Y. Itoh, S. Arii, et al., Activation of B-Myb by E2F1 in hepatocellular carcinoma, Hepatol. Res. 38 (2008) 886-895.
18. H. Huynh, P.T. Do, T.H. Nguyen, P. Chow, P.H. Tan, T.H. Quach, T. Van, K.C. Soo, E. Tran, Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma, Int. J. Oncol. 25 (2004) 1839-1847.
19. H. Murakami, N.D. Sanderson, P. Nagy, P.A. Marino, G. Merlino, S.S. Thorgeirsson, Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis, Cancer Res. 53 (1993) 1719-1723.
20. E.A. Conner, E.R. Lemmer, M. Omori, P.J. Wirth, V.M. Factor, S.S. Thorgeirsson, Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis, Oncogene 19 (2000) 5054-5062.
21. N. Dyson, The regulation of E2F by pRB-family proteins, Genes Dev. 12 (1998) 2245-2262.
22. J.R. Nevins, G. Leone, J. DeGregori, L. Jakoi, Role of the Rb/E2F pathway in cell growth control, J. Cell. Physiol. 173 (1997) 233-236.
23. J. DeGregori, G. Leone, A. Miron, L. Jakoi, J.R. Nevins, Distinct roles for E2F proteins in cell growth control and apoptosis, Proc. Natl. Acad. Sci. USA 94 (1997) 7245-7250.
24. D.G. Johnson, J.K. Schwarz, W.D. Cress, J.R. Nevins, Expression of transcription factor E2F1 induces quiescent cells to enter S phase, Nature 365 (1993) 349-352.
25. L. Kaczmarek, J.K. Hyland, R. Watt, M. Rosenberg, R. Baserga, Microinjected cmyc as a competence factor, Science 228 (1985) 1313-1315.
26. T.F. Kowalik, J. DeGregori, G. Leone, L. Jakoi, J.R. Nevins, E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2, Cell Growth Differ. 9 (1998) 113-118.
27. H. Hermeking, D. Eick, Mediation of c-Myc-induced apoptosis by p53, Science 265 (1994) 2091-2093.
28. X. Wu, A.J. Levine, P53 and E2F-1 cooperate to mediate apoptosis, Proc. Natl. Acad. Sci. USA 91 (1994) 3602-3606.
29. H.M. El Tayebi, K.A. Hosny, G. Esmat, K. Breuhahn, A.I. Abdelaziz, MiR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma, FEBS Lett. 586 (2012) 3309-3316.
30. T. Nussbaum, J. Samarin, V. Ehemann, M. Bissinger, E. Ryschich, A. Khamidjanov, X. Yu, N. Gretz, P. Schirmacher, K. Breuhahn, Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis, Hepatology 48 (2008) 146-156.
31. J.N. Davis, K.J. Wojno, S. Daignault, M.D. Hofer, R. Kuefer, M.A. Rubin, M.L. Day, Elevated E2F1 inhibits transcription of the androgen receptor in metastatic hormone-resistant prostate cancer, Cancer Res. 66 (2006) 11897-11906.
32. S. Ladu, D.F. Calvisi, E.A. Conner, M. Farina, V.M. Factor, S.S. Thorgeirsson, E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer, Gastroenterology 135 (2008) 1322-1332.
33. F. Sahin, T.L. Sladek, E2F-1 has dual roles depending on the cell cycle, Int. J. Biol. Sci. 6 (2010) 116-128.